preterm infants. It has also confirmed the serious prognostic significance of the most florid lesions of periventricular leucomalacia, which results from hypoxic-ischaemic brain injury. Follow up studies of cohorts of preterm infants prospectively studied with ultrasound imaging leave us in little doubt that hypoxic-ischaemic injury is a more important cause of permanent neurodevelopmental disability in surviving very preterm infants than periventricular haemorrhage. Birth asphyxia in infants born at full term also causes hypoxic-ischaemic injury to the brain and accounts for more disabled survivors in the community than result from very preterm birth.'
It seems clear that hypoxic-ischaemic injury is the commonest cause of perinatally acquired damage to the brain.
The purpose of this review is to describe two relatively new methods for the non-invasive investigation of this type of brain injury: magnetic resonance spectroscopy and near infrared spectroscopy. They provide complementary information about cerebral oxygenation and haemodynamics and are likely to become widely used for clinical as well as research purposes.
Magnetic resonance spectroscopy
The first observations of the human brain by magnetic resonance spectroscopy were made in the early 1980s from newborn infants.2 3 For observations to be made, the baby has to be transported to the spectrometer and inserted within the bore of a superconducting magnet. The studies are conducted well within National Radiological Protection Board guidelines and the technique seems completely safe, provided that care is taken to exclude ferromagnetic metal from the vicinity of the magnet. The infants can be monitored and if necessary mechanically ventilated during the studies, but ethical constraints preclude the transport of unstable babies to the magnet for research purposes. Magnetic resonance spectroscopy can be used to measure the concentrations in brain tissue of phos- 15 In newborn rabbits the results of bicarbonate infusion after moderate hypoxaemia have also been observed. 16 The main finding was that in none of the studies were important adverse effects in reducing intracellular pH detected-a conclusion that seems at variance with previous investigations using other methods in adult animals. Other forms of hypoxic-ischaemic injury Abnormal phosphorus spectra indicating impaired oxidative phosphorylation and closely resembling those found in babies with birth asphyxia have been found in a variety of other conditions where hypoxicischaemic injury was suspected, including periventricular leucomalacia, cerebral infarction, and intraparenchymal periventricular haemorrhage.10 12 13 26 Also, investigations of babies selected for study because of increased cerebral echodensities suggestive of various types of hypoxic-ischaemic injury have shown that oxidative phosphorylation in brain tissue was quite often impaired.19 26 Although detailed information is limited, the temporal progression of the spectral abnormalities in all these conditions seems similar to that which follows birth asphyxia, with the implication that the initiating cerebral insult was often around the time of birth. A further implication (at least theoretically) is that cerebroprotective agents may in the future find a role in preventing or ameliorating permanent ill effects-as in the case of birth asphyxia. Conceivably, antenatal protection may eventually become possible in infants at extremely high risk. Electrons are generated by the activity of the citric acid cycle. These pass along the respiratory electron transport chain, which is situated in the inner mitochondrial membrane, and provide an electrical potential that leads to the regeneration of ATP from ADP and Pi. At the end of the chain, the electrons reduce cytochrome aa3, which then becomes reoxidised by interaction with molecular oxygen. This reaction accounts for about 95% of the oxygen consumption of the body.
Near infrared spectroscopy permits changes in the concentrations in brain tissue of oxyhaemoglobin, deoxyhaemoglobin, and oxidised cytochrome aa3 to be measured. The Oxyhaemoglobin, deoxyhaemoglobin, and oxidised cytochrome aa3 are chromophores which absorb near infrared light in predictable ways. The absorption characteristics of the tissue therefore give information about the presence of these compounds within it. Brazy et al were the first to obtain data from the brains of newborn infants, but quantitation of the compounds was not at that time possible.29 30 Quantitative spectroscopy, first performed on newborn infants in 1986,31 depends on the relation between optical absorption and the concentration of chromophore present. The Beer-Lambert law describing optical absorption may be expressed as: absorption (OD)=(acLB)+G, where OD is optical densities, a is the absorption coefficient of the chromophore (mM-'cm-1), c is concentration (mM), L is the distance between the points where light enters and leaves the tissue (cm), B is a 'path length factor' that takes account of the scattering of light in the tissue (which causes the optical pathlength to be greater than L), and G is a factor related to the geometry of the tissue. If L, B, and G remain constant, then changes in chromophore concentration can be obtained from the expression: Ac= AOD/aLB.
The absorption coefficients of oxyhaemoglobin and deoxyhaemoglobin have been obtained from in vitro studies, and of cytochrome aa3 from observations from the brain in rats given exchange transfusions of a fluorocarbon blood substitute to remove haemoglobin.32 The pathlength factor B has been obtained by several different methods,3'-33 including time of flight measurements of an ultrashort pulse of light across the head.33 These methods gave a value for B of about 4-3 and this is the value now used for quantitation of oxyhaemoglobin, deoxyhaemoglobin, and oxidised cytochrome aa3 in the brains of newborn infants. In practice, absorption at several different wavelengths is measured and an algorithm is used to convert changes in optical absorption to changes in concentration.12 31 32 (Absorption by chromophores in extracerebral tissues is negligible.)
OBSERVATIONS IN NEWBORN INFANTS
For the observations to be made, new portable apparatus has been designed and built.4 Near infrared light at the requisite wavelengths is transmitted into the parietal region through a flexible fibreoptic bundle, and light emerging from the opposite parietal region is collected by an identical bundle and conveyed to a sensitive photomultiplier tube. The infants: (a) born at 29 weeks' gestation and studied aged I day, and (b) born at 36 weeks' gestation and studied aged 4 days. Both infants had hyaline membrane disease necessitating mechanical ventilation. Changes are shown during: a-alterations in SaO2, which was reducedfrom 95% to 88% atfive minutes and then returned to 95%. b-alterations in PaCO2, which increasedfrom 6-1 kPa to 7-2 kPa at 12 minutes, and then fell to 6-2 kPa. As expected alterations in SaO2 were followed by approximately reciprocal changes in oxyhaemoglobin and deoxyhaemoglobin. The increase in PaCO2 caused a rise in oxyhaemoglobin but no change in deoxyhaemoglobin, presumably because ofan associated increase in cerebral bloodflow. (ml-100 g1l)=(Aoxyhaemoglobin-Adeoxyhaemoglobin)/2(tHb-R-ASaO2) where tHb is the central total haemoglobin concentration (mMm1-F), and R is the cerebral:large vessel haematocrit ratio (assumed to be 0-69).
Mean cerebral blood volume in 12 preterm and full term newborn infants undergoing intensive care who were thought to have normal brains was 1*7 ml*100 g-', whereas in 10 comparable infants with brain injury (mostly hypoxic-ischaemic) cerebral blood volume was significantly higher, 3-0 ml-100 g7l (JS Wyatt, M Cope, DT The extent of abnormalities detected by magnetic resonance spectroscopy has prognostic implications: evidence of severe energy failure in the first days of life was regularly associated with subsequent death or with severe neurodevelopmental impairments.
Many technical developments in magnetic resonance spectroscopy are under way, particularly employing proton ('H) spectroscopy, which will allow the intracerebral concentrations of a wide range of metabolites, including neurotransmitters, to be measured. The combination of spectroscopy with magnetic resonance imaging will permit quantitative data to be obtained from selected volumes within the brain.
Near infrared spectroscopy is used to make observations at the cotside of the intracerebral concentrations of the chromophores oxyhaemoglobin, deoxyhaemoglobin, and oxidised cytochrome aa3, and it therefore provides information complementary to that obtained by magnetic resonance spectroscopy. Measurements can also be made of cerebral blood flow, cerebral blood volume, and other haemodynamic indices; in addition, the reactivity of the cerebral circulation can be tested. The effects of therapeutic manoeuvres and drugs such as indomethacin can be observed. Near infrared spectroscopy is already providing information about the haemodynamic events that precede and accompany secondary energy failure in newborn infants
